Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
CAS Number:
[2049079-64-1]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted